Illumina (ILMN)
Illumina stock today
Illumina closed at $202.61 on November 17, 2026. Over the past year it returned +68.7% with dividends reinvested, against +11.2% for the S&P 500. Its market value is $30.6 billion.
| Period | ILMN | S&P 500 (SPY) |
|---|---|---|
| 1 month | -22.8% | -4.0% |
| 3 months | +4.9% | -5.0% |
| Year to date | +54.5% | +8.2% |
| 1 year | +68.7% | +11.2% |
| 3 years | +120.8% | +68.5% |
| 5 years | -44.8% | +67.3% |
Key statistics
- Market value
- $30.6B
- P/E (trailing)
- 34.9
- Forward P/E
- 33.8
- Price / sales
- 6.7
- 52-week range
- $114.44 to $293.69
About Illumina
Makes DNA sequencing instruments, reagents and software used in genomic research and clinical testing.
Sector: Health Care · Industry: Life Sciences Tools & Services
More on Illumina
- Financials: revenue, earnings and segmentsRevenue -1% in the year to Dec 2025
- Valuation: P/E history and peersP/E 34.9, median 49.2 at 7 of its last 10 year ends
- Returns: what $1,000 became$1,000 ten years ago is $1,553 today
No forecast, no recommendation. This page describes Illumina from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Nov 17, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.